Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=27034904
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Mycoplasma genitalium: An Emerging Sexually Transmitted Infection
#MMPMID27034904
Munoz JL
; Goje OJ
Scientifica (Cairo)
2016[]; 2016
(?): 7537318
PMID27034904
show ga
Mycoplasma genitalium has been recognized as a cause of male urethritis, and
there is now evidence suggesting that it causes cervicitis and pelvic
inflammatory disease in women. M. genitalium is a slow growing organism, and,
with the advent of nucleic acid amplification test (NAAT), more studies are being
performed, and knowledge about the pathogenicity of this organism elucidated.
With NAAT detection, treatment modalities have been studied, and the next
challenge is to determine the most effective antimicrobial therapy. Doxycycline,
the first-line antibiotic for urethritis, is largely ineffective in the treatment
of M. genitalium and furthermore, resistance to macrolide has also emerged. The
most effective drug is Moxifloxacin although there are emerging reports of
resistance to it in various parts of the world. This paper not only highlights
the current research and knowledge, but also reviews the diversity of health
implications on the health of men and women infected with M. genitalium.
Alternate antibiotics and the impact of M. genitalium on infertility are areas
that require more studies as we continue to research into this microorganism.